ERG and prostate cancer: Moreover, recent publication shows how NOTCH pathway inhibition antagonizes the growth and invasion of TMPERSS2-ERG positive prostate cancer cells (ERG overexpressing prostate tumor) (Kron et al., 2017) suggesting an important role of the cascade in tumor growth.